Searched for
WEIGHT LOSS TREATMENT
GLP-1 prices drop at Mochi Health, starting at $60 but what will patients actually pay?Mochi Health has reduced their prices for their GLP-1 weight loss medications. While the membership fees is entirely separate, they have me...- SC ruling deals a heavy blow to Yes Bank's risk equity capitalYes Bank is facing a significant reduction in its Common Equity Tier-1 capital buffer following a recent Supreme Court ruling. The court re...
- Sebi revises CAS rules, changes derivatives expiry settlement methodologySebi has announced changes to the closing auction session for the equity cash market, which will begin in December 2026. The revised sessio...
- ETMarkets Smart Talk| Redirect fresh SIPs to largecaps if mid and smallcaps dominate your portfolio: Pradeep GuptaPradeep Gupta, Chairman & MD, Anand Rathi Share and Stock Brokers Limited, explains why largecaps offer greater valuation comfort, how inve...
- GLP-1 and fertility: Could weight-loss medicines help women conceive? Here's what new reports revealinsulin resistance can disrupt reproductive hormones. For women with polycystic ovary syndrome (PCOS), ovulation may become irregular. Gett...
- Pope Leo cancer diagnosis: What is lung adenocarcinoma, symptoms, treatments & who are at riskPope Leo has been found to have lung adenocarcinoma, which is among the most common types of lung cancer. He recently had surgery to excise...
- Pope Leo XIV, diagnosed with lung cancer, undergoes surgery. What is lung adenocarcinoma? 7 symptoms you should not ignoreAdenocarcinoma is a type of cancer that arises from glandular or secretory cells. Adenocarcinoma is the predominant variant of lung cancer....
- ‘DWTS’ pro Gleb Savchenko accuses ex-wife of giving teen daughter weight-loss medication arbitrarily as custody battle escalatesIn a heated custody dispute, Gleb Savchenko is accusing his former partner Elena Samodanova of endangering their daughter Olivia's well-bei...
- Susan Dell’s ‘$50K MAGA makeover’ sparks frenzy: Why is Michael Dell’s wife trending after White House visit?Susan Dell, wife of Dell Technologies CEO Michael Dell, has sparked online buzz after her recent White House appearance alongside Donald Tr...
- FSSAI pulls up Dr Reddy's, Nestle Health Science over Celevida claimsThe Food Safety and Standards Authority of India (FSSAI) said the product was advertised as providing high-protein support for preserving l...
- Hair fall decoded: Causes, triggers, and warning signsFor many, hair shedding can raise concerns, with various elements at play like stress, hormonal imbalances, and nutrition. Recognizing the ...
- WHO seeks more information from Russia on Irkutsk lab worker's deathTedros Adhanom Ghebreyesus of WHO reported on a laboratory worker's death in Irkutsk due to severe pneumonia. Initial reports suggested a p...
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
- WHO says medicines, surgery not first-line treatment for childhood obesityThe World Health Organization has released guidelines on treating obesity among children and adolescents. It emphasizes structured diets, p...
- Nobel 2026: Ozempic, Mounjaro research tipped for medicine prizeThe 2026 Nobel season is set to reveal the winners of various prestigious awards, starting with medicine. The medicine prize is anticipated...
- From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to IndiaIndia’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- GLP-1 users are suing over vision loss: What does the evidence really show?Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately...
- Ozempic maker Novo Nordisk sets sights on hair-loss marketThe condition is part of a list of areas, including addiction and menopause, where Novo sees potential overlap with either its core scienti...
- Wegovy maker Novo Nordisk faces investor pressure to find growth beyond weight-loss drugsFacing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...
Load More
